TME Pharma N.V. Strategic Asset Allocation Index
TME Pharma N.V. strategic asset allocation index. TME Pharma N.V. (ALTME) has a Strategic Asset Allocation Index of 2.1% as of December 2024. Strategic assets (PP&E of €34.00K plus long-term investments of €-) total €34.00K, measured against net assets of €1.61 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ALTME equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of TME Pharma N.V. (2020–2024)
Strategic asset allocation index of TME Pharma N.V. from 2020 to 2024. This chart shows how TME Pharma N.V.'s Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2024. As of December 2024, the index stands at 2.1%, representing strategic assets of €34.00K against net assets of €1.61 Million EUR. Check TME Pharma N.V. tangible equity quality to evaluate the tangible quality of the company's equity base.
TME Pharma N.V. Strategic Asset Allocation Index by Year (2020–2024)
TME Pharma N.V. strategic asset allocation index by year from 2020 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for TME Pharma N.V. from 2020 to 2024, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is TME Pharma N.V. worth.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 2.1% | €34.00K | €34.00K | €- | €1.61 Million | ▲ +0.6 pp |
| 2021 | 1.5% | €66.00K | €66.00K | €- | €4.50 Million | ▼ -0.1 pp |
| 2020 | 1.5% | €118.00K | €118.00K | €- | €7.70 Million | — |